Shaperon Inc. (KOSDAQ: 378800)

South Korea flag South Korea · Delayed Price · Currency is KRW
3,790.00
-125.00 (-3.19%)
Jan 21, 2025, 3:00 PM KST
23.05%
Market Cap 114.24B
Revenue (ttm) 91.24M
Net Income (ttm) -15.90B
Shares Out 30.14M
EPS (ttm) -632.39
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 872,764
Average Volume 3,896,808
Open 3,845.00
Previous Close 3,915.00
Day's Range 3,755.00 - 3,890.00
52-Week Range 1,389.00 - 5,900.00
Beta -0.04
RSI 47.76
Earnings Date Mar 21, 2025

About Shaperon

Shaperon Inc., a clinical stage biotech company, develops novel inflammasome inhibitors targeting immune-mediated inflammatory disorders with high unmet medical needs and nanobody therapeutics. It offers NuGel, a gel type atopic dermatitis drug candidate in Phase 2 clinical trials; and NuSepin, an IV injection form of HY209 in Phase 2 clinical trials for use in the treatment of systemic inflammatory response syndrome. The company also provides Oral HY209, an oral formulation of HY209 for use in the treatment of neuroinflammatory diseases; and H... [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 2008
Employees 50
Stock Exchange KOSDAQ
Ticker Symbol 378800
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.